Vitamin D3

Generic Name: Vitamin D3

Brand Names: Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₄₄O

CAS Number: 67-97-0

Unique Ingredient Identifier: 1C6V77QF41

Background: Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalcifero...

Indication: Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .
...

Associated Conditions: Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture

Associated Therapies: Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Clinical Trials

The Association of Vitamin D Supplementation With the Outcome in Critically Ill Children

Phase 4

Completed

Conditions: Critically Ill

Interventions: Drug: Normal saline
Drug: Vitamin D

First Posted Date: 2020-09-03

Last Posted Date: 2020-09-03

Lead Sponsor: Dr Mustahsin Khalil

Target Recruit Count: 96

Registration Number: NCT04536831

Locations: 🇵🇰
King Edward Medical University Lahore, Lahore, Punjab, Pakistan

Efficacy of Vitamin D Supplementation to Prevent the Risk of Acquiring COVID-19 in Healthcare Workers

Phase 3

Completed

Conditions: Vitamin D
Covid19

Interventions: Drug: Cholecalciferol

First Posted Date: 2020-09-02

Last Posted Date: 2021-12-22

Lead Sponsor: Coordinación de Investigación en Salud, Mexico

Target Recruit Count: 321

Registration Number: NCT04535791

Locations: 🇲🇽
Hospital Centro Medico Nacional Siglo XXI, Mexico City, Distrito Federal, Mexico

Efficacy of Vitamin D Treatment in Pediatric Patients Hospitalized by COVID-19

Phase 3

Completed

Conditions: Children, Only
Covid19
Vitamin D

Interventions: Drug: Cholecalciferol

First Posted Date: 2020-08-06

Last Posted Date: 2022-04-08

Lead Sponsor: Coordinación de Investigación en Salud, Mexico

Target Recruit Count: 45

Registration Number: NCT04502667

Locations: 🇲🇽
Hospital Centro Medico Nacional Siglo XXI, Mexico City, Distrito Federal, Mexico

Vitamin D and Methotrexate Adverse Effects

Conditions: Acute Lymphoblastic Leukemia

First Posted Date: 2020-07-27

Last Posted Date: 2020-07-27

Lead Sponsor: Assiut University

Target Recruit Count: 50

Registration Number: NCT04488237

The Efficacy and the Safety of Vitamin D3 30,000 IU for Loading Dose Schedules

Phase 3

Completed

Conditions: Vitamin D Deficiency

Interventions: Drug: Cholecalciferol

First Posted Date: 2020-07-20

Last Posted Date: 2022-03-04

Lead Sponsor: Semmelweis University

Target Recruit Count: 75

Registration Number: NCT04476511

Locations: 🇭🇺
Szalay János Outpatient Clinic, Hajdúnánás, Hungary
🇭🇺
Semmelweis University - Dept. of Medicine and Oncology, Budapest, Hungary
🇭🇺
Uno Medical Trials Kft., Budapest, Hungary

and more 4 locations

Vitamin D in Egyptian Children With Atopic Dermatitis

Phase 3

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Placebo
Drug: Vitamin D

First Posted Date: 2020-07-13

Last Posted Date: 2020-07-14

Lead Sponsor: National Hepatology & Tropical Medicine Research Institute

Target Recruit Count: 92

Registration Number: NCT04468711

Locations: 🇪🇬
NHTRMI, Cairo, Egypt

Vitamin D Regulates the Expression of Glucocorticoid Receptors in Blood of Severe Asthmatic Patients

Not Applicable

Completed

Conditions: Effect of Drug

Interventions: Other: Placebo
Drug: Vitamin D

First Posted Date: 2020-06-23

Last Posted Date: 2020-06-23

Lead Sponsor: Dubai Health Authority

Target Recruit Count: 45

Registration Number: NCT04443387

Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Routine treatment
Drug: Vitamin D3

First Posted Date: 2020-06-19

Last Posted Date: 2020-06-19

Lead Sponsor: Baqiyatallah Medical Sciences University

Target Recruit Count: 187

Registration Number: NCT04439474

Locations: 🇮🇷
Mohammad Sadegh Bagheri Baghdasht, Tehran, Iran, Islamic Republic of

Cholecalciferol to Improve the Outcomes of COVID-19 Patients

Phase 4

Completed

Conditions: COVID

Interventions: Drug: Vitamin D
Drug: Placebo

First Posted Date: 2020-06-02

Last Posted Date: 2021-07-30

Lead Sponsor: Vitamin D Study Group

Target Recruit Count: 218

Registration Number: NCT04411446

Locations: 🇦🇷
Hospital de Alta Complejidad en Red El Cruce, Florencio Varela, Buenos Aires, Argentina

Oral Colecalciferol Treatment in Spinal Cord Lesion

Not Applicable

Completed

Conditions: Spinal Cord Injury

Interventions: Drug: Vitamin D3

First Posted Date: 2020-05-26

Last Posted Date: 2021-02-12

Lead Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Target Recruit Count: 60

Registration Number: NCT04400747

Locations: 🇹🇷
Istanbul Physical Medicine Rehabilitation Training & Research Hospital, İstanbul, Turkey

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy